Global Retirement Partners, LLC Puma Biotechnology, Inc. Transaction History
Global Retirement Partners, LLC
- $4.24 Billion
- Q3 2025
A detailed history of Global Retirement Partners, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 1,492 shares of PBYI stock, worth $7,698. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,492
Previous 1,492
-0.0%
Holding current value
$7,698
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PBYI
# of Institutions
126Shares Held
33.3MCall Options Held
68.2KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.13MShares$21.3 Million9.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.71MShares$19.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$18.4 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.01MShares$10.4 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.87MShares$9.67 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $235M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...